We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
-9.76%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$210M
AUM Growth
-$8.84M
Cap. Flow
+$15.6M
Cap. Flow %
7.42%
Top 10 Hldgs %
25.12%
Holding
107
New
6
Increased
45
Reduced
11
Closed
7

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$2.36M
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$924K
3
CVS icon
CVS Health
CVS
+$731K
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$717K
5
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$689K

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$2.86M
2
GE icon
GE Aerospace
GE
+$1.29M
3
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
+$951K
4
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$435K
5
OIH icon
VanEck Oil Services ETF
OIH
+$415K

Sector Composition

Rank Sector Weight
1 Technology 13.92%
2 Healthcare 13.24%
3 Industrials 12.66%
4 Consumer Staples 11.68%
5 Financials 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$7.46M 3.55%
73,463
+2,750
+4% +$295K
CSCO icon
2
Cisco
CSCO
$444B
$6.04M 2.88%
139,444
+12,185
+10% +$558K
INTC icon
3
Intel
INTC
$504B
$5.68M 2.71%
121,054
+13,005
+12% +$609K
MA icon
4
Mastercard
MA
$469B
$5.39M 2.57%
28,567
+2,915
+11% +$579K
WMT icon
5
Walmart Inc
WMT
$863B
$4.79M 2.28%
154,113
+11,940
+8% +$383K
ABT icon
6
Abbott
ABT
$175B
$4.75M 2.26%
65,652
+7,550
+13% +$531K
ABBV icon
7
AbbVie
ABBV
$454B
$4.74M 2.26%
51,419
+5,930
+13% +$521K
MMM icon
8
3M
MMM
$87.5B
$4.66M 2.22%
29,279
+3,935
+16% +$653K
BRK.B icon
9
Berkshire Hathaway Class B
BRK.B
$1.06T
$4.66M 2.22%
22,813
+2,665
+13% +$557K
IVV icon
10
iShares Core S&P 500 ETF
IVV
$875B
$4.58M 2.18%
18,202
+1,695
+10% +$460K
MCD icon
11
McDonald's
MCD
$187B
$4.57M 2.18%
25,762
+1,170
+5% +$207K
FAST icon
12
Fastenal
FAST
$53B
$4.53M 2.16%
346,752
+43,360
+14% +$587K
AAPL icon
13
Apple
AAPL
$4.72T
$4.52M 2.15%
114,660
+7,580
+7% +$367K
XYL icon
14
Xylem
XYL
$27.8B
$4.41M 2.1%
66,032
+9,900
+18% +$685K
IJR icon
15
iShares Core S&P Small-Cap ETF
IJR
$109B
$4.21M 2%
60,695
+3,226
+6% +$249K
PEP icon
16
PepsiCo
PEP
$184B
$4.2M 2%
37,998
+2,090
+6% +$236K
CHRW icon
17
C.H. Robinson
CHRW
$24.2B
$4.16M 1.98%
49,426
+7,100
+17% +$635K
KO icon
18
Coca-Cola
KO
$349B
$4.12M 1.96%
87,004
+5,550
+7% +$266K
MDT icon
19
Medtronic
MDT
$105B
$4.07M 1.94%
44,736
+4,100
+10% +$383K
IEMG icon
20
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
$4.06M 1.93%
86,041
+3,431
+4% +$166K
PG icon
21
Procter & Gamble
PG
$342B
$4.04M 1.92%
43,922
+3,120
+8% +$279K
TSCO icon
22
Tractor Supply
TSCO
$15.9B
$3.97M 1.89%
237,900
+21,250
+10% +$381K
COP icon
23
ConocoPhillips
COP
$146B
$3.91M 1.86%
62,666
+8,300
+15% +$565K
ACN icon
24
Accenture
ACN
$84.9B
$3.73M 1.78%
26,466
+480
+2% +$75.9K
MRK icon
25
Merck
MRK
$322B
$3.66M 1.74%
50,146
+4,737
+10% +$334K
1
2 3 4 5

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
CWM
Cordatus Wealth Management Newtown, Pennsylvania $420M AUM 24.63% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
LSWM
Lorne Steinberg Wealth Management Montreal, Quebec, Canada $422M AUM 23.86% 1-Year Est. Return
IMA
Investment Management Associates Greenwood Village, Colorado $420M AUM 11.81% 1-Year Est. Return

Boston Research & Management's Q4 2018 Portfolio in Review

As of Q4 2018, Boston Research & Management held 107 positions worth $210M, down 4% from $219M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Boston Research & Management deployed $15.6M of net new capital in Q4 2018, opening 6 new positions and adding to 45 existing holdings. Its largest new stake was Linde: 14,930 shares worth $2.33M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was GE Aerospace, an estimated $1.29M trimmed.

  • Boston Research & Management's largest Q4 2018 buy was Linde: 14,930 shares worth $2.33M.
  • Boston Research & Management added most to CVS Health in Q4 2018, an estimated $731K increase.
  • Boston Research & Management's biggest Q4 2018 reduction was GE Aerospace, cutting an estimated $1.29M.
  • Boston Research & Management fully exited Praxair Inc in Q4 2018, selling an estimated $2.86M.
  • Boston Research & Management's ten largest holdings make up 25% of its $210M portfolio in Q4 2018.
  • Boston Research & Management opened 6 new positions and closed 7 in Q4 2018.
  • Boston Research & Management's portfolio value fell 4% quarter-over-quarter to $210M.

Based on Boston Research & Management's 13F filing for Q4 2018, filed 6 Feb 2019.